Allergies – A T cells perspective in the era beyond the TH1/TH2 paradigm

Clinical Immunology

Volumn 174, Issue , 2017, Pages 73-83

  Berker, Moritz ^a   Frank, Larissa Johanna ^a   Geßner, Anja Lidwina ^a   Grassl, Niklas ^a   Holtermann, Anne Verena ^a   Höppner, Stefanie ^a   Kraef, Christian ^a   Leclaire, Martin Dominik ^a   Maier, Pia ^a   Messerer, David Alexander Christian ^a   Möhrmann, Lino ^a   Nieke, Jan Philipp ^a   Schoch, Diana ^a   Soll, Dominik ^a   Woopen, Christina Marianne Paulina ^a  

^a Studienstiftung des deutschen Volkes   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 9; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IL9 PROTEIN, HUMAN;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY; ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; ATOPY; DISEASE SEVERITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-9; T-LYMPHOCYTE SUBSETS;

EID: 85002412583     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2016.11.001     Document Type: Review

References (186)

1. [1] Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., Coffman, R.L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. Baltim. Md 1950 136 (1986), 2348–2357.
2. [2] Romagnani, S., The Th1/Th2 paradigm. Immunol. Today 18 (1997), 263–266, 10.1016/S0167-5699(97)80019-9.
3. [3] Sher, A., Coffman, R.L., Hieny, S., Cheever, A.W., Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. Baltim. Md 1950 145 (1990), 3911–3916.
4. [4] McCoy, K.D., Köller, Y., New developments providing mechanistic insight into the impact of the microbiota on allergic disease. Clin. Immunol. 159 (2015), 170–176, 10.1016/j.clim.2015.05.007.
5. [5] Robinson, D.S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A.M., Corrigan, C., Durham, S.R., Kay, A.B., Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326 (1992), 298–304, 10.1056/NEJM199201303260504.
6. [6] Swain, S.L., Weinberg, A.D., English, M., Huston, G., IL-4 directs the development of Th2-like helper effectors. J. Immunol. Baltim. Md 1950 145 (1990), 3796–3806.
7. [7] Zheng, W., Flavell, R.A., The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89 (1997), 587–596.
8. [8] Kurata, H., Lee, H.J., O'Garra, A., Arai, N., Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11 (1999), 677–688.
9. [9] Renauld, J.C., Goethals, A., Houssiau, F., Merz, H., Van Roost, E., Van Snick, J., Human P40/IL-9. Expression in activated CD4 + T cells, genomic organization, and comparison with the mouse gene. J. Immunol. Baltim. Md 1950 144 (1990), 4235–4241.
10. [10] Fiorentino, D.F., Bond, M.W., Mosmann, T.R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170 (1989), 2081–2095.
11. [11] Traidl-Hoffmann, C., Mariani, V., Hochrein, H., Karg, K., Wagner, H., Ring, J., Mueller, M.J., Jakob, T., Behrendt, H., Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J. Exp. Med. 201 (2005), 627–636, 10.1084/jem.20041065.
12. [12] Hammad, H., Chieppa, M., Perros, F., Willart, M.A., Germain, R.N., Lambrecht, B.N., House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nat. Med. 15 (2009), 410–416, 10.1038/nm.1946.
13. [13] Newton, G.K., Perrior, T.R., Jenkins, K., Major, M.R., Key, R.E., Stewart, M.R., Firth-Clark, S., Lloyd, S.M., Zhang, J., Francis-Newton, N.J., Richardson, J.P., Chen, J., Lai, P., Garrod, D.R., Robinson, C., The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen Der p 1: an innovative approach to the treatment of allergic asthma. J. Med. Chem. 57 (2014), 9447–9462, 10.1021/jm501102h.
14. [14] Ogawa, T., Takai, T., Kato, T., Kikuchi, Y., Niyonsaba, F., Ikeda, S., Okumura, K., Ogawa, H., Upregulation of the release of granulocyte-macrophage colony-stimulating factor from keratinocytes stimulated with cysteine protease activity of recombinant major mite allergens, Der f 1 and Der p 1. Int. Arch. Allergy Immunol. 146 (2008), 27–35, 10.1159/000112500.
15. [15] Traidl-Hoffmann, C., Jakob, T., Behrendt, H., Determinants of allergenicity. J. Allergy Clin. Immunol. 123 (2009), 558–566, 10.1016/j.jaci.2008.12.003.
16. [16] Korematsu, S., Tanaka, Y., Hosoi, S., Koyanagi, S., Yokota, T., Mikami, B., Minato, N., C8/119S mutation of major mite allergen Derf-2 leads to degenerate secondary structure and molecular polymerization and induces potent and exclusive Th1 cell differentiation. J. Immunol. Baltim. Md 1950 165 (2000), 2895–2902.
17. [17] Chambers, L., Brown, A., Pritchard, D.I., Sreedharan, S., Brocklehurst, K., Kalsheker, N.A., Enzymatically active papain preferentially induces an allergic response in mice. Biochem. Biophys. Res. Commun. 253 (1998), 837–840, 10.1006/bbrc.1998.9862.
18. [18] Jackson, D.J., Makrinioti, H., Rana, B.M.J., Shamji, B.W.H., Trujillo-Torralbo, M.-B., Footitt, J., Del-Rosario, n.J., Telcian, A.G., Nikonova, A., Zhu, J., Aniscenko, J., Gogsadze, L., Bakhsoliani, E., Traub, S., Dhariwal, J., Porter, J., Hunt, D., Hunt, T., Hunt, T., Stanciu, L.A., Khaitov, M., Bartlett, N.W., Edwards, M.R., Kon, O.M., Mallia, P., Papadopoulos, N.G., Akdis, C.A., Westwick, J., Edwards, M.J., Cousins, D.J., Walton, R.P., Johnston, S.L., IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 190 (2014), 1373–1382, 10.1164/rccm.201406-1039OC.
19. [19] Ito, T., TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202 (2005), 1213–1223, 10.1084/jem.20051135.
20. [20] Akasaki, S., Matsushita, K., Kato, Y., Fukuoka, A., Iwasaki, N., Nakahira, M., Fujieda, S., Yasuda, K., Yoshimoto, T., Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways. Int. Immunol. 28 (2016), 65–76, 10.1093/intimm/dxv055.
21. [21] Hammad, H., Plantinga, M., Deswarte, K., Pouliot, P., Willart, M.A.M., Kool, M., Muskens, F., Lambrecht, B.N., Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J. Exp. Med. 207 (2010), 2097–2111, 10.1084/jem.20101563.
22. [22] Sokol, C.L., Chu, N.-Q., Yu, S., Nish, S.A., Laufer, T.M., Medzhitov, R., Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat. Immunol. 10 (2009), 713–720, 10.1038/ni.1738.
23. [23] Bradding, P., Feather, I.H., Howarth, P.H., Mueller, R., Roberts, J.A., Britten, K., Bews, J.P., Hunt, T.C., Okayama, Y., Heusser, C.H., Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176 (1992), 1381–1386.
24. [24] Noval Rivas, M., Burton, O.T., Oettgen, H.C., Chatila, T., IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. J. Allergy Clin. Immunol, 2016, 10.1016/j.jaci.2016.02.030.
25. [25] van Panhuys, N., Tang, S.-C., Prout, M., Camberis, M., Scarlett, D., Roberts, J., Hu-Li, J., Paul, W.E., Le Gros, G., In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 12423–12428, 10.1073/pnas.0806372105.
26. [26] Kirstein, F., Nieuwenhuizen, N.E., Jayakumar, J., Horsnell, W.G.C., Brombacher, F., Role of IL-4 receptor α-positive CD4(+) T cells in chronic airway hyperresponsiveness. J. Allergy Clin. Immunol, 2015, 10.1016/j.jaci.2015.10.036.
27. [27] Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T.K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D.M., Bazan, J.F., Kastelein, R.A., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (2005), 479–490, 10.1016/j.immuni.2005.09.015.
28. [28] Anderson, E.L., Kobayashi, T., Iijima, K., Bartemes, K.R., Chen, C.-C., Kita, H., IL-33 mediates reactive eosinophilopoiesis in response to airborne allergen exposure. Allergy, 2016, 10.1111/all.12861.
29. [29] Piehler, D., Eschke, M., Schulze, B., Protschka, M., Müller, U., Grahnert, A., Richter, T., Heyen, L., Köhler, G., Brombacher, F., Alber, G., The IL-33 receptor (ST2) regulates early IL-13 production in fungus-induced allergic airway inflammation. Mucosal Immunol, 2015, 10.1038/mi.2015.106.
30. [30] Soumelis, V., Reche, P.A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., Smith, K., Gorman, D., Zurawski, S., Abrams, J., Menon, S., McClanahan, T., de Waal-Malefyt Rd, R., Bazan, F., Kastelein, R.A., Liu, Y.-J., Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3 (2002), 673–680, 10.1038/ni805.
31. [31] Bogiatzi, S.I., Fernandez, I., Bichet, J.-C., Marloie-Provost, M.-A., Volpe, E., Sastre, X., Soumelis, V., Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J. Immunol. Baltim. Md 1950 178 (2007), 3373–3377.
32. [32] Allakhverdi, Z., Comeau, M.R., Jessup, H.K., Yoon, B.-R.P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S.F., Sarfati, M., Delespesse, G., Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 204 (2007), 253–258, 10.1084/jem.20062211.
33. [33] Henriquez, O.A., Den Beste, K., Hoddeson, E.K., Parkos, C.A., Nusrat, A., Wise, S.K., House dust mite allergen Der p 1 effects on sinonasal epithelial tight junctions. Int. Forum Allergy Rhinol. 3 (2013), 630–635, 10.1002/alr.21168.
34. [34] Tai, H.-Y., Tam, M.F., Chou, H., Peng, H.-J., Su, S.-N., Perng, D.-W., Shen, H.-D., Pen ch 13 allergen induces secretion of mediators and degradation of occludin protein of human lung epithelial cells. Allergy 61 (2006), 382–388, 10.1111/j.1398-9995.2005.00958.x.
35. [35] Tjota, M.Y., Hrusch, C.L., Blaine, K.M., Williams, J.W., Barrett, N.A., Sperling, A.I., Signaling through FcRγ-associated receptors on dendritic cells drives IL-33–dependent TH2-type responses. J. Allergy Clin. Immunol. 134 (2014), 706–713, e8, 10.1016/j.jaci.2014.06.013.
36. [36] Takai, T., Kato, T., Ota, M., Yasueda, H., Kuhara, T., Okumura, K., Ogawa, H., Recombinant Der p 1 and Der f 1 with in vitro enzymatic activity to cleave human CD23, CD25 and alpha1-antitrypsin, and in vivo IgE-eliciting activity in mice. Int. Arch. Allergy Immunol. 137 (2005), 194–200, 10.1159/000086331.
37. [37] Barnes, P.J., Th2 cytokines and asthma: an introduction. Respir. Res. 2:2 (2001), 64–65, 10.1186/rr39.
38. [38] Pulendran, B., Artis, D., New paradigms in type 2 immunity. Science 337 (2012), 431–435, 10.1126/science.1221064.
39. [39] Chang, H.-C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G.L., Jabeen, R., McKinley, C., Ahyi, A.-N., Han, L., Nguyen, E.T., Robertson, M.J., Perumal, N.B., Tepper, R.S., Nutt, S.L., Kaplan, M.H., The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11 (2010), 527–534, 10.1038/ni.1867.
40. [40] Deo, S., Mistry, K., Kakade, A., Niphadkar, P., Role played by Th2 type cytokines in IgE mediated allergy and asthma. Lung India, 27, 2010, 66, 10.4103/0970-2113.63609.
41. [41] Packard, K.A., Khan, M.M., Effects of histamine on Th1/Th2 cytokine balance. Int. Immunopharmacol. 3 (2003), 909–920, 10.1016/S1567-5769(02)00235-7.
42. [42] Varga, E.M., Wachholz, P., Nouri-Aria, K.T., Verhoef, A., Corrigan, C.J., Till, S.J., Durham, S.R., T cells from human allergen-induced late asthmatic responses express IL-12 receptor 2 subunit mRNA and respond to IL-12 in vitro. J. Immunol. 165 (2000), 2877–2885, 10.4049/jimmunol.165.5.2877.
43. [43] Dabbagh, K., Takeyama, K., Lee, H.M., Ueki, I.F., Lausier, J.A., Nadel, J.A., IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. Baltim. Md 1950 162 (1999), 6233–6237.
44. [44] Licona-Limón, P., Kim, L.K., Palm, N.W., Flavell, R.A., TH2, allergy and group 2 innate lymphoid cells. Nat. Immunol. 14 (2013), 536–542, 10.1038/ni.2617.
45. [45] Wills-Karp, M., Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202 (2004), 175–190, 10.1111/j.0105-2896.2004.00215.x.
46. [46] Kau, A.L., Korenblat, P.E., Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes. Curr. Opin. Allergy Clin. Immunol. 14 (2014), 570–575, 10.1097/ACI.0000000000000108.
47. [47] Vatrella, A., Fabozzi, I., Calabrese, C., Maselli, R., Pelaia, G., Dupilumab: a novel treatment for asthma. J. Asthma Allergy 7 (2014), 123–130, 10.2147/JAA.S52387.
48. [48] Wenzel, S., Castro, M., Corren, J., Maspero, J., Wang, L., Zhang, B., Pirozzi, G., Sutherland, E.R., Evans, R.R., Joish, V.N., Eckert, L., Graham, N.M.H., Stahl, N., Yancopoulos, G.D., Louis-Tisserand, M., Teper, A., Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet Lond. Engl. 388 (2016), 31–44, 10.1016/S0140-6736(16)30307-5.
49. [49] Shimizu, H., Obase, Y., Katoh, S., Mouri, K., Kobashi, Y., Oka, M., Critical role of interleukin-5 in the development of a mite antigen-induced chronic bronchial asthma model. Inflamm. Res. 62 (2013), 911–917, 10.1007/s00011-013-0651-y.
50. [50] Leckie, M.J., ten Brinke, A., Khan, J., Diamant, Z., O'Connor, B.J., Walls, C.M., Mathur, A.K., Cowley, H.C., Chung, K.F., Djukanovic, R., Hansel, T.T., Holgate, S.T., Sterk, P.J., Barnes, P.J., Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet Lond. Engl. 356 (2000), 2144–2148.
51. [51] Ortega, H.G., Liu, M.C., Pavord, I.D., Brusselle, G.G., FitzGerald, J.M., Chetta, A., Humbert, M., Katz, L.E., Keene, O.N., Yancey, S.W., Chanez, P., MENSA Investigators, Mepolizumab treatment in patients with severe eosinophilic asthma. N. Engl. J. Med. 371 (2014), 1198–1207, 10.1056/NEJMoa1403290.
52. [52] Howell, M.D., Fairchild, H.R., Kim, B.E., Bin, L., Boguniewicz, M., Redzic, J.S., Hansen, K.C., Leung, D.Y.M., Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J. Invest. Dermatol. 128 (2008), 2248–2258, 10.1038/jid.2008.74.
53. [53] Brandt, E.B., Th2 cytokines and atopic dermatitis. J. Clin. Cell. Immunol., 02, 2011, 10.4172/2155-9899.1000110.
54. [54] Oldhoff, J.M., Darsow, U., Werfel, T., Katzer, K., Wulf, A., Laifaoui, J., Hijnen, D.J., Plötz, S., Knol, E.F., Kapp, A., Bruijnzeel-Koomen, C.A.F.M., Ring, J., de Bruin-Weller, M.S., Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy 60 (2005), 693–696, 10.1111/j.1398-9995.2005.00791.x.
55. [55] Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., Glimcher, L.H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000), 655–669.
56. [56] Szabo, S.J., Sullivan, B.M., Peng, S.L., Glimcher, L.H., Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21 (2003), 713–758, 10.1146/annurev.immunol.21.120601.140942.
57. [57] Finotto, S., Neurath, M.F., Glickman, J.N., Qin, S., Lehr, H.A., Green, F.H.Y., Ackerman, K., Haley, K., Galle, P.R., Szabo, S.J., Drazen, J.M., De Sanctis, G.T., Glimcher, L.H., Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295 (2002), 336–338, 10.1126/science.1065544.
58. [58] Cohn, L., Homer, R.J., Niu, N., Bottomly, K., T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J. Exp. Med. 190 (1999), 1309–1318.
59. [59] Mitchell, C., Provost, K., Niu, N., Homer, R., Cohn, L., IFN-γ acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease. J. Immunol. 187 (2011), 3815–3820.
60. [60] Iwamoto, I., Nakajima, H., Endo, H., Yoshida, S., Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4 + T cells. J. Exp. Med. 177 (1993), 573–576.
61. [61] Zhao, Y., Yang, J., Gao, Y.-D., Altered expressions of helper T cell (Th) 1, Th2, and Th17 cytokines in CD8 + and γδ T cells in patients with allergic asthma. J. Asthma 48 (2011), 429–436.
62. [62] Reinhold, U., Pawelec, G., Wehrmann, W., Herold, M., Wernet, P., Kreysel, H.W., Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-gamma and neopterin in patients with severe atopic dermatitis. Int. Arch. Allergy Immunol. 87 (1988), 120–126.
63. [63] Imada, M., Simons, F.E., Jay, F.T., Hayglass, K.T., Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls. Immunology, 85, 1995, 373.
64. [64] Varga, E.M., Jacobson, M.R., Till, S.J., Masuyama, K., O'Brien, F., Durham, S.R., Rak, S., Lund, V., Scadding, G.K., Hamid, Q.A., Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis. Allergy 54 (1999), 338–345.
65. [65] Yu, M., Eckart, M.R., Morgan, A.A., Mukai, K., Butte, A.J., Tsai, M., Galli, S.J., Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. J. Clin. Invest. 121 (2011), 3133–3143.
66. [66] Grewe, M., Gyufko, K., Schöpf, E., Krutmann, J., Lesional expression of interferon-γ in atopic eczema. Lancet 343 (1994), 25–26.
67. [67] Chen, L., Martinez, O., Overbergh, L., Mathieu, C., Prabhakar, B.S., Chan, L.S., Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin. Exp. Immunol. 138 (2004), 375–387.
68. [68] Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M., Weaver, C.T., Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005), 1123–1132, 10.1038/ni1254.
69. [69] Romani, L., Immunity to fungal infections. Nat. Rev. Immunol. 4 (2004), 11–24, 10.1038/nri1255.
70. [70] Manel, N., Unutmaz, D., Littman, D.R., The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol. 9 (2008), 641–649, 10.1038/ni.1610.
71. [71] Zielinski, C.E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., Sallusto, F., Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 484 (2012), 514–518, 10.1038/nature10957.
72. [72] Noster, R., de Koning, H., Sallusto, F., Zielinski, C., Two types of human Th17 cells with pro- and anti-inflammatory properties and distinct roles in autoinflammation. Pediatr. Rheumatol. Online J., 13, 2015, O49, 10.1186/1546-0096-13-S1-O49.
73. [73] Chakir, J., Shannon, J., Molet, S., Fukakusa, M., Elias, J., Laviolette, M., Boulet, L.-P., Hamid, Q., Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111 (2003), 1293–1298, 10.1067/mai.2003.1557.
74. [74] Molet, S., Hamid, Q., Davoine, F., Nutku, E., Taha, R., Pagé, N., Olivenstein, R., Elias, J., Chakir, J., IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108 (2001), 430–438, 10.1067/mai.2001.117929.
75. [75] Agache, I., Akdis, C.A., Endotypes of allergic diseases and asthma: an important step in building blocks for the future of precision medicine. Allergol. Int. 65 (2016), 243–252, 10.1016/j.alit.2016.04.011.
76. [76] Vroman, H., van den Blink, B., Kool, M., Mode of dendritic cell activation: the decisive hand in Th2/Th17 cell differentiation. Implications in asthma severity?. Immunobiology 220 (2015), 254–261, 10.1016/j.imbio.2014.09.016.
77. [77] Newcomb, D.C., Peebles, R.S. Jr., Th17-mediated inflammation in asthma. Curr. Opin. Immunol. 25 (2013), 755–760, 10.1016/j.coi.2013.08.002.
78. [78] Oda, N., Canelos, P.B., Essayan, D.M., Plunkett, B.A., Myers, A.C., Huang, S.-K., Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am. J. Respir. Crit. Care Med. 171 (2005), 12–18, 10.1164/rccm.200406-778OC.
79. [79] Al-Ramli, W., Préfontaine, D., Chouiali, F., Martin, J.G., Olivenstein, R., Lemière, C., Hamid, Q., TH17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy Clin. Immunol. 123 (2009), 1185–1187, 10.1016/j.jaci.2009.02.024.
80. [80] Sorbello, V., Ciprandi, G., Di Stefano, A., Massaglia, G.M., Favatà, G., Conticello, S., Malerba, M., Folkerts, G., Profita, M., Rolla, G., Ricciardolo, F.L.M., Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma. Allergy 70 (2015), 236–240, 10.1111/all.12547.
81. [81] Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V., Fossiez, F., Ryffel, B., Schnyder, B., Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203 (2006), 2715–2725, 10.1084/jem.20061401.
82. [82] Quan, S.-H., Zhang, Y.-L., Han, D.H., Iwakura, Y., Rhee, C.-S., Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model. Ann. Allergy Asthma Immunol. 108 (2012), 342–350, 10.1016/j.anai.2012.02.014.
83. [83] Cheng, X., Lou, W., Wang, C., Zhang, W., Han, D., Zhang, L., FOXP3-marked IL-17a-producing regulatory T cells are increased in patients with allergic rhinitis. Acta Otolaryngol. (Stockh.) 132 (2012), 1311–1317, 10.3109/00016489.2012.709320.
84. [84] G. Ciprandi, G. Filaci, F. Battaglia, D. Fenoglio, Peripheral Th-17 cells in allergic rhinitis: new evidence, Int. Immunopharmacol. 2010 (n.d.) 226–229.
85. [85] Baumann, R., Rabaszowski, M., Stenin, I., Tilgner, L., Scheckenbach, K., Wiltfang, J., Schipper, J., Chaker, A., Wagenmann, M., Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge. Am. J. Rhinol. Allergy 27 (2013), 266–272, 10.2500/ajra.2013.27.3913.
86. [86] Ciprandi, G., De Amici, M., Murdaca, G., Fenoglio, D., Ricciardolo, F., Marseglia, G., Tosca, M., Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 64 (2009), 1375–1378, 10.1111/j.1398-9995.2009.02010.x.
87. [87] Dhingra, N., Guttman-Yassky, E., A possible role for IL-17A in establishing Th2 inflammation in murine models of atopic dermatitis. J. Invest. Dermatol. 134 (2014), 2071–2074, 10.1038/jid.2014.141.
88. [88] Gittler, J.K., Shemer, A., Suárez-Fariñas, M., Fuentes-Duculan, J., Gulewicz, K.J., Wang, C.Q.F., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J.G., Guttman-Yassky, E., Progressive activation of Th2/Th22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J. Allergy Clin. Immunol. 130 (2012), 1344–1354, 10.1016/j.jaci.2012.07.012.
89. [89] Hoff, S., Oyoshi, M.K., Macpherson, A., Geha, R.S., The microbiota is important for IL-17A expression and neutrophil infiltration in lesional skin of Flgft/ft mice. Clin. Immunol. 156 (2015), 128–130, 10.1016/j.clim.2014.12.001.
90. [90] Heo, W.I., Lee, K.E., Hong, J.Y., Kim, M.N., Oh, M.S., Kim, Y.S., Kim, K.W., Kim, K.E., Sohn, M.H., The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis. Clin. Exp. Dermatol. 40 (2015), 665–671, 10.1111/ced.12567.
91. [91] Oyoshi, M.K., Murphy, G.F., Geha, R.S., Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J. Allergy Clin. Immunol. 124 (2009), 485–493, e1, 10.1016/j.jaci.2009.05.042.
92. [92] Wolk, K., Kunz, S., Asadullah, K., Sabat, R., Cutting edge: immune cells as sources and targets of the IL-10 family members?. J. Immunol. Baltim. Md 1950 168 (2002), 5397–5402.
93. [93] Volpe, E., Touzot, M., Servant, N., Marloie-Provost, M.-A., Hupé, P., Barillot, E., Soumelis, V., Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood 114 (2009), 3610–3614, 10.1182/blood-2009-05-223768.
94. [94] Rutz, S., Eidenschenk, C., Ouyang, W., IL-22, not simply a Th17 cytokine. Immunol. Rev. 252 (2013), 116–132, 10.1111/imr.12027.
95. [95] Sallusto, F., Zielinski, C.E., Lanzavecchia, A., Human Th17 subsets. Eur. J. Immunol. 42 (2012), 2215–2220, 10.1002/eji.201242741.
96. [96] Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., Sallusto, F., Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10 (2009), 857–863, 10.1038/ni.1767.
97. [97] Fitzgerald-Bocarsly, P., Dai, J., Singh, S., Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 19 (2008), 3–19, 10.1016/j.cytogfr.2007.10.006.
98. [98] Wolk, K., Haugen, H.S., Xu, W., Witte, E., Waggie, K., Anderson, M., Vom Baur, E., Witte, K., Warszawska, K., Philipp, S., Johnson-Leger, C., Volk, H.-D., Sterry, W., Sabat, R., IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J. Mol. Med. Berl. Ger. 87 (2009), 523–536, 10.1007/s00109-009-0457-0.
99. [99] Sonnenberg, G.F., Nair, M.G., Kirn, T.J., Zaph, C., Fouser, L.A., Artis, D., Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J. Exp. Med. 207 (2010), 1293–1305, 10.1084/jem.20092054.
100. [100] Nograles, K.E., Zaba, L.C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K.C., White, T.R., Pensabene, C., Coats, I., Novitskaya, I., Lowes, M.A., Krueger, J.G., Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159 (2008), 1092–1102, 10.1111/j.1365-2133.2008.08769.x.
101. [101] Wolk, K., Witte, E., Wallace, E., Döcke, W.-D., Kunz, S., Asadullah, K., Volk, H.-D., Sterry, W., Sabat, R., IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36 (2006), 1309–1323, 10.1002/eji.200535503.
102. [102] Li, W., Danilenko, D.M., Bunting, S., Ganesan, R., Sa, S., Ferrando, R., Wu, T.D., Kolumam, G.A., Ouyang, W., Kirchhofer, D., The serine protease marapsin is expressed in stratified squamous epithelia and is up-regulated in the hyperproliferative epidermis of psoriasis and regenerating wounds. J. Biol. Chem. 284 (2009), 218–228, 10.1074/jbc.M806267200.
103. [103] Zheng, Y., Danilenko, D.M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., Ouyang, W., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007), 648–651, 10.1038/nature05505.
104. [104] Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., Sabat, R., IL-22 increases the innate immunity of tissues. Immunity 21 (2004), 241–254, 10.1016/j.immuni.2004.07.007.
105. [105] Souwer, Y., Szegedi, K., Kapsenberg, M.L., de Jong, E.C., IL-17 and IL-22 in atopic allergic disease. Curr. Opin. Immunol. 22 (2010), 821–826, 10.1016/j.coi.2010.10.013.
106. [106] Nograles, K.E., Zaba, L.C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J.G., Guttman-Yassky, E., IL-22-producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 123 (2009), 1244–1252, e2, 10.1016/j.jaci.2009.03.041.
107. [107] Zhao, Y., Yang, J., Gao, Y.-D., Guo, W., Th17 immunity in patients with allergic asthma. Int. Arch. Allergy Immunol. 151 (2010), 297–307, 10.1159/000250438.
108. [108] Czarnowicki, T., Esaki, H., Gonzalez, J., Malajian, D., Shemer, A., Noda, S., Talasila, S., Berry, A., Gray, J., Becker, L., Estrada, Y., Xu, H., Zheng, X., Suárez-Fariñas, M., Krueger, J.G., Paller, A.S., Guttman-Yassky, E., Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets. J. Allergy Clin. Immunol. 136 (2015), 941–951, e3, 10.1016/j.jaci.2015.05.049.
109. [109] Tang, J., Xiao, P., Luo, X., Bai, J., Xia, W., Chen, W., Li, J., Yu, Q., Shi, S., Xu, Y., Mou, Z., Wang, Y., Li, H., Increased IL-22 level in allergic rhinitis significantly correlates with clinical severity. Am. J. Rhinol. Allergy 28 (2014), 197–201, 10.2500/ajra.2014.28.4088.
110. [110] Dyring-Andersen, B., Skov, L., Løvendorf, M.B., Bzorek, M., Søndergaard, K., Lauritsen, J.-P.H., Dabelsteen, S., Geisler, C., Bonefeld, C.M., CD4(+) T cells producing interleukin (IL)-17, IL-22 and interferon-γ are major effector T cells in nickel allergy. Contact Dermatitis 68 (2013), 339–347, 10.1111/cod.12043.
111. [111] Farfariello, V., Amantini, C., Nabissi, M., Morelli, M.B., Aperio, C., Caprodossi, S., Carlucci, A., Bianchi, A.M., Santoni, G., IL-22 mRNA in peripheral blood mononuclear cells from allergic rhinitic and asthmatic pediatric patients. Pediatr. Allergy Immunol. 22 (2011), 419–423, 10.1111/j.1399-3038.2010.01116.x.
112. [112] Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., Stockinger, B., Transforming growth factor-beta “reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9 (2008), 1341–1346, 10.1038/ni.1659.
113. [113] Schmitt, E., Germann, T., Goedert, S., Hoehn, P., Huels, C., Koelsch, S., Kühn, R., Müller, W., Palm, N., Rüde, E., IL-9 production of naive CD4 + T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. Baltim. Md 1950 153 (1994), 3989–3996.
114. [114] Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R.A., Mitsdoerffer, M., Strom, T.B., Elyaman, W., Ho, I.-C., Khoury, S., Oukka, M., Kuchroo, V.K., IL-4 inhibits TGF-beta-induced Foxp3 + T cells and, together with TGF-beta, generates IL-9 + IL-10 + Foxp3(−) effector T cells. Nat. Immunol., 2008, 1347–1355, 10.1038/ni.1677.
115. [115] Veldhoen, et al. Transforming growth factor-b “reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset. Nat. Immunol. 9 (2008), 1341–1346, 10.1038/ni.1659.
116. [116] Veldhoen, M., Interferon regulatory factor 4: combinational control of lymphocyte differentiation. Immunity 33 (2010), 141–143, 10.1016/j.immuni.2010.08.007.
117. [117] Townsend, J.M., Fallon, G.P., Matthews, J.D., Smith, P., Jolin, E.H., McKenzie, N.A., IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13 (2000), 573–583.
118. [118] Temann, U.-A., Ray, P., Flavell, R.A., Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109 (2002), 29–39, 10.1172/JCI13696.
119. [119] Yao, W., Zhang, Y., Jabeen, R., Nguyen, E.T., Wilkes, D.S., Tepper, R.S., Kaplan, M.H., Zhou, B., Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38 (2013), 360–372, 10.1016/j.immuni.2013.01.007.
120. [120] Jabeen, R., Goswami, R., Awe, O., Kulkarni, A., Nguyen, E.T., Attenasio, A., Walsh, D., Olson, M.R., Kim, M.H., Tepper, R.S., Sun, J., Kim, C.H., Taparowsky, E.J., Zhou, B., Kaplan, M.H., Th9 cell development requires a BATF-regulated transcriptional network. J. Clin. Invest. 123 (2013), 4641–4653, 10.1172/JCI69489.
121. [121] Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Ulges, A., Taube, C., Dehzad, N., Becker, M., Stassen, M., Steinborn, A., Lohoff, M., Schild, H., Schmitt, E., Bopp, T., Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33 (2010), 192–202, 10.1016/j.immuni.2010.07.014.
122. [122] Tamiya, T., Ichiyama, K., Kotani, H., Fukaya, T., Sekiya, T., Shichita, T., Honma, K., Yui, K., Matsuyama, T., Nakao, T., Fukuyama, S., Inoue, H., Nomura, M., Yoshimura, A., Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction. J. Immunol. Baltim. Md 1950 191 (2013), 2360–2371, 10.4049/jimmunol.1301276.
123. [123] Kaplan, M.H., Hufford, M.M., Olson, M.R., The development and in vivo function of T helper 9 cells. Nat. Rev. Immunol. 15 (2015), 295–307, 10.1038/nri3824.
124. [124] Sehra, S., Yao, W., Nguyen, E.T., Glosson-Byers, N.L., Akhtar, N., Zhou, B., Kaplan, M.H., TH9 cells are required for tissue mast cell accumulation during allergic inflammation. J. Allergy Clin. Immunol. 136 (2015), 433–440, e1, 10.1016/j.jaci.2015.01.021.
125. [125] Wilhelm, C., Hirota, K., Stieglitz, B., Van Snick, J., Tolaini, M., Lahl, K., Sparwasser, T., Helmby, H., Stockinger, B., An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12 (2011), 1071–1077, 10.1038/ni.2133.
126. [126] Hoppenot, D., Malakauskas, K., Lavinskienė, S., Bajoriūnienė, I., Kalinauskaitė, V., Sakalauskas, R., Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients. Medicina (Mex.) 51 (2015), 10–17, 10.1016/j.medici.2015.01.001.
127. [127] Ma, L., Xue, H.-B., Guan, X.-H., Shu, C.-M., Zhang, J.-H., Yu, J., Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin. Exp. Immunol. 175 (2014), 25–31, 10.1111/cei.12198.
128. [128] Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., Becher, B., RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12 (2011), 560–567, 10.1038/ni.2027.
129. [129] El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B.N., Rostami, A., The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12 (2011), 568–575, 10.1038/ni.2031.
130. [130] Noster, R., Riedel, R., Mashreghi, M.-F., Radbruch, H., Harms, L., Haftmann, C., Chang, H.-D., Radbruch, A., Zielinski, C.E., IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci. Transl. Med., 6, 2014, 241ra80, 10.1126/scitranslmed.3008706.
131. [131] Sheng, W., Yang, F., Zhou, Y., Yang, H., Low, P.Y., Kemeny, D.M., Tan, P., Moh, A., Kaplan, M.H., Zhang, Y., Fu, X.-Y., STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation. Cell Res. 24 (2014), 1387–1402, 10.1038/cr.2014.154.
132. [132] Santarlasci, V., Maggi, L., Capone, M., Querci, V., Beltrame, L., Cavalieri, D., D'Aiuto, E., Cimaz, R., Nebbioso, A., Liotta, F., De Palma, R., Maggi, E., Cosmi, L., Romagnani, S., Annunziato, F., Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 36 (2012), 201–214, 10.1016/j.immuni.2011.12.013.
133. [133] Acciani, T.H., Suzuki, T., Trapnell, B.C., Le Cras, T.D., Epidermal growth factor receptor signalling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic airway disease. Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol. 46 (2016), 317–328, 10.1111/cea.12612.
134. [134] Lei, X.F., Ohkawara, Y., Stämpfli, M.R., Gauldie, J., Croitoru, K., Jordana, M., Xing, Z., Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation. Clin. Exp. Immunol. 113 (1998), 157–165.
135. [135] Ohta, K., Yamashita, N., Tajima, M., Miyasaka, T., Nakano, J., Nakajima, M., Ishii, A., Horiuchi, T., Mano, K., Miyamoto, T., Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: essential role of GM-CSF. J. Allergy Clin. Immunol. 104 (1999), 1024–1030.
136. [136] Linden, M., Svensson, C., Andersson, M., Greiff, L., Andersson, E., Denburg, J.A., Persson, C.G., Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Allergy 54 (1999), 212–219.
137. [137] Girolomoni, G., Pastore, S., The role of keratinocytes in the pathogenesis of atopic dermatitis. J. Am. Acad. Dermatol. 45 (2001), S25–S28.
138. [138] Pastore, S., Mascia, F., Girolomoni, G., The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur. J. Dermatol. 16 (2006), 125–131.
139. [139] Wilkowska, A., Gleń, J., Zabłotna, M., Trzeciak, M., Ryduchowska, M., Sobjanek, M., Nedoszytko, B., Nowicki, R., Sokołowska-Wojdyło, M., The association of GM-CSF − 677A/C promoter gene polymorphism with the occurrence and severity of atopic dermatitis in a Polish population. Int. J. Dermatol. 53 (2014), e172–e174, 10.1111/ijd.12245.
140. [140] Rafatpanah, H., Bennett, E., Pravica, V., McCoy, M.J., David, T.J., Hutchinson, I.V., Arkwright, P.D., Association between novel GM-CSF gene polymorphisms and the frequency and severity of atopic dermatitis. J. Allergy Clin. Immunol. 112 (2003), 593–598.
141. [141] Saeki, H., Tsunemi, Y., Asano, N., Nakamura, K., Sekiya, T., Hirai, K., Kakinuma, T., Fujita, H., Kagami, S., Tamaki, K., Analysis of GM-CSF gene polymorphisms (3606T/C and 3928C/T) in Japanese patients with atopic dermatitis. Clin. Exp. Dermatol. 31 (2006), 278–280, 10.1111/j.1365-2230.2005.02052.x.
142. [142] Shi, H.-Z., Li, S., Xie, Z.-F., Qin, X.-J., Qin, X., Zhong, X.-N., Regulatory CD4 + CD25 + T lymphocytes in peripheral blood from patients with atopic asthma. Clin. Immunol. 113 (2004), 172–178, 10.1016/j.clim.2004.06.009.
143. [143] Josefowicz, S.Z., Lu, L.-F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30 (2012), 531–564, 10.1146/annurev.immunol.25.022106.141623.
144. [144] Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., Wahl, S.M., Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25 + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003), 1875–1886, 10.1084/jem.20030152.
145. [145] Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., Meylan, F., Siegel, R., Hennighausen, L., Shevach, E.M., O'shea, J.J., Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007), 371–381, 10.1016/j.immuni.2007.02.009.
146. [146] Josefowicz, S.Z., Niec, R.E., Kim, H.Y., Treuting, P., Chinen, T., Zheng, Y., Umetsu, D.T., Rudensky, A.Y., Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482 (2012), 395–399, 10.1038/nature10772.
147. + T cells. Science 349 (2015), 989–993, 10.1126/science.aac4263.
148. [148] Torgerson, T.R., Linane, A., Moes, N., Anover, S., Mateo, V., Rieux–Laucat, F., Hermine, O., Vijay, S., Gambineri, E., Cerf–Bensussan, N., Fischer, A., Ochs, H.D., Goulet, O., Ruemmele, F.M., Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 132 (2007), 1705–1717, 10.1053/j.gastro.2007.02.044.
149. [149] Barzaghi, F., Passerini, L., Bacchetta, R., Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front. Immunol., 3, 2012, 10.3389/fimmu.2012.00211.
150. [150] Tulic, M.K., Andrews, D., Crook, M.L., Charles, A., Tourigny, M.R., Moqbel, R., Prescott, S.L., Changes in thymic regulatory T-cell maturation from birth to puberty: differences in atopic children. J. Allergy Clin. Immunol. 129 (2012), 199–206, e4, 10.1016/j.jaci.2011.10.016.
151. [151] Akdis, C.A., Akdis, M., Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol. 123 (2009), 735–746, 10.1016/j.jaci.2009.02.030.
152. [152] Satoguina, J.S., Adjobimey, T., Arndts, K., Hoch, J., Oldenburg, J., Layland, L.E., Hoerauf, A., Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-β. Eur. J. Immunol. 38 (2008), 3101–3113, 10.1002/eji.200838193.
153. [153] Ulges, A., Klein, M., Reuter, S., Gerlitzki, B., Hoffmann, M., Grebe, N., Staudt, V., Stergiou, N., Bohn, T., Brühl, T.-J., Muth, S., Yurugi, H., Rajalingam, K., Bellinghausen, I., Tuettenberg, A., Hahn, S., Reißig, S., Haben, I., Zipp, F., Waisman, A., Probst, H.-C., Beilhack, A., Buchou, T., Filhol-Cochet, O., Boldyreff, B., Breloer, M., Jonuleit, H., Schild, H., Schmitt, E., Bopp, T., Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nat. Immunol. 16 (2015), 267–275, 10.1038/ni.3083.
154. [154] Fyhrquist, N., Lehtimäki, S., Lahl, K., Savinko, T., Lappeteläinen, A.-M., Sparwasser, T., Wolff, H., Lauerma, A., Alenius, H., Foxp3 + cells control Th2 responses in a murine model of atopic dermatitis. J. Invest. Dermatol. 132 (2012), 1672–1680, 10.1038/jid.2012.40.
155. [155] Chen, W., Regulatory T cells use “itch” to control asthma. J. Clin. Invest. 123 (2013), 4576–4578, 10.1172/JCI72477.
156. [156] Wang, Y., Souabni, A., Flavell, R.A., Wan, Y.Y., An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in vivo. J. Immunol. Baltim. Md 1950 185 (2010), 5983–5992, 10.4049/jimmunol.1001255.
157. [157] Pillemer, B.B.L., Qi, Z., Melgert, B., Oriss, T.B., Ray, P., Ray, A., STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. J. Immunol. Baltim. Md 1950 183 (2009), 155–163, 10.4049/jimmunol.0803733.
158. [158] Ray, A., Khare, A., Krishnamoorthy, N., Qi, Z., Ray, P., Regulatory T cells in many flavors control asthma. Mucosal Immunol. 3 (2010), 216–229, 10.1038/mi.2010.4.
159. [159] Hartl, D., Koller, B., Mehlhorn, A.T., Reinhardt, D., Nicolai, T., Schendel, D.J., Griese, M., Krauss-Etschmann, S., Quantitative and functional impairment of pulmonary CD4 + CD25hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 119 (2007), 1258–1266, 10.1016/j.jaci.2007.02.023.
160. [160] Thorburn, A.N., Brown, A.C., Nair, P.M., Chevalier, N., Foster, P.S., Gibson, P.G., Hansbro, P.M., Pneumococcal components induce regulatory T cells that attenuate the development of allergic airways disease by deviating and suppressing the immune response to allergen. J. Immunol. Baltim. Md 1950 191 (2013), 4112–4120, 10.4049/jimmunol.1201232.
161. [161] Brugnolo, F., Sampognaro, S., Liotta, F., Cosmi, L., Annunziato, F., Manuelli, C., Campi, P., Maggi, E., Romagnani, S., Parronchi, P., The novel synthetic immune response modifier R-848 (resiquimod) shifts human allergen-specific CD4 + TH2 lymphocytes into IFN-gamma-producing cells. J. Allergy Clin. Immunol. 111 (2003), 380–388.
162. [162] Filì, L., Ferri, S., Guarna, F., Sampognaro, S., Manuelli, C., Liotta, F., Cosmi, L., Matucci, A., Vultaggio, A., Annunziato, F., Maggi, E., Guarna, A., Romagnani, S., Parronchi, P., Redirection of allergen-specific TH2 responses by a modified adenine through toll-like receptor 7 interaction and IL-12/IFN release. J. Allergy Clin. Immunol. 118 (2006), 511–517, 10.1016/j.jaci.2006.05.027.
163. [163] Gajewski, T.F., Fitch, F.W., Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. Baltim. Md 1950 140 (1988), 4245–4252.
164. [164] Maggi, E., Parronchi, P., Manetti, R., Simonelli, C., Piccinni, M.P., Rugiu, F.S., De Carli, M., Ricci, M., Romagnani, S., Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. Baltim. Md 1950 148 (1992), 2142–2147.
165. [165] Hegazy, A.N., Peine, M., Helmstetter, C., Panse, I., Fröhlich, A., Bergthaler, A., Flatz, L., Pinschewer, D.D., Radbruch, A., Löhning, M., Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 32 (2010), 116–128, 10.1016/j.immuni.2009.12.004.
166. [166] Peine, M., Rausch, S., Helmstetter, C., Fröhlich, A., Hegazy, A.N., Kühl, A.A., Grevelding, C.G., Höfer, T., Hartmann, S., Löhning, M., Stable T-bet(+)GATA-3(+) Th1/Th2 hybrid cells arise in vivo, can develop directly from naive precursors, and limit immunopathologic inflammation. PLoS Biol., 11, 2013, e1001633, 10.1371/journal.pbio.1001633.
167. [167] Wang, Y.-H., Voo, K.S., Liu, B., Chen, C.-Y., Uygungil, B., Spoede, W., Bernstein, J.A., Huston, D.P., Liu, Y.-J., A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 207 (2010), 2479–2491, 10.1084/jem.20101376.
168. [168] Irvin, C., Zafar, I., Good, J., Rollins, D., Christianson, C., Gorska, M.M., Martin, R.J., Alam, R., Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J. Allergy Clin. Immunol. 134 (2014), 1175–1186, e7, 10.1016/j.jaci.2014.05.038.
169. [169] Panzer, M., Sitte, S., Wirth, S., Drexler, I., Sparwasser, T., Voehringer, D., Rapid in vivo conversion of effector T cells into Th2 cells during helminth infection. J. Immunol. Baltim. Md 1950 188 (2012), 615–623, 10.4049/jimmunol.1101164.
170. [170] Hegazy, A.N., Peine, M., Helmstetter, C., Panse, I., Fröhlich, A., Bergthaler, A., Flatz, L., Pinschewer, D.D., Radbruch, A., Löhning, M., Interferons direct Th2 cell reprogramming to generate a stable GATA-3 + T-bet + cell subset with combined Th2 and Th1 cell functions. Immunity 32 (2010), 116–128, 10.1016/j.immuni.2009.12.004.
171. [171] Krawczyk, C.M., Shen, H., Pearce, E.J., Functional plasticity in memory T helper cell responses. J. Immunol. Baltim. Md 1950 178 (2007), 4080–4088.
172. [172] Koch, M.A., Tucker-Heard, G.'s., Perdue, N.R., Killebrew, J.R., Urdahl, K.B., Campbell, D.J., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10 (2009), 595–602, 10.1038/ni.1731.
173. [173] Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., Cui, K., Kanno, Y., Roh, T.-Y., Watford, W.T., Schones, D.E., Peng, W., Sun, H.-W., Paul, W.E., O'Shea, J.J., Zhao, K., Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4 + T cells. Immunity 30 (2009), 155–167, 10.1016/j.immuni.2008.12.009.
174. [174] Mantel, P.-Y., Kuipers, H., Boyman, O., Rhyner, C., Ouaked, N., Rückert, B., Karagiannidis, C., Lambrecht, B.N., Hendriks, R.W., Crameri, R., Akdis, C.A., Blaser, K., Schmidt-Weber, C.B., GATA3-driven Th2 responses inhibit TGF-β1–induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol., 5, 2007, e329, 10.1371/journal.pbio.0050329.
175. [175] Provoost, S., Maes, T., van Durme, Y.M., Gevaert, P., Bachert, C., Schmidt-Weber, C.B., Brusselle, G.G., Joos, G.F., Tournoy, K.G., Decreased FOXP3 protein expression in patients with asthma. Allergy 64 (2009), 1539–1546, 10.1111/j.1398-9995.2009.02056.x.
176. [176] Noval Rivas, M., Burton, O.T., Wise, P., Charbonnier, L.-M., Georgiev, P., Oettgen, H.C., Rachid, R., Chatila, T.A., Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity 42 (2015), 512–523, 10.1016/j.immuni.2015.02.004.
177. [177] Diller, M.L., Kudchadkar, R.R., Delman, K.A., Lawson, D.H., Ford, M.L., Balancing inflammation: the link between Th17 and regulatory T cells. Mediat. Inflamm., 2016, 2016, 6309219, 10.1155/2016/6309219.
178. [178] Sefik, E., Geva-Zatorsky, N., Oh, S., Konnikova, L., Zemmour, D., McGuire, A.M., Burzyn, D., Ortiz-Lopez, A., Lobera, M., Yang, J., Ghosh, S., Earl, A., Snapper, S.B., Jupp, R., Kasper, D., Mathis, D., Benoist, C., Individual intestinal symbionts induce a distinct population of RORγ + regulatory T cells. Science 349 (2015), 993–997, 10.1126/science.aaa9420.
179. [179] Lathrop, S.K., Bloom, S.M., Rao, S.M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D.A., Stappenbeck, T.S., Hsieh, C.-S., Peripheral education of the immune system by colonic commensal microbiota. Nature 478 (2011), 250–254, 10.1038/nature10434.
180. [180] Josefowicz, S.Z., Niec, R.E., Kim, H.Y., Treuting, P., Chinen, T., Zheng, Y., Umetsu, D.T., Rudensky, A.Y., Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482 (2012), 395–399, 10.1038/nature10772.
181. [181] Panzer, M., Sitte, S., Wirth, S., Drexler, I., Sparwasser, T., Voehringer, D., Rapid in vivo conversion of effector T cells into Th2 cells during helminth infection. J. Immunol. Baltim. Md 1950 188 (2012), 615–623, 10.4049/jimmunol.1101164.
182. [182] Berry, M., Brightling, C., Pavord, I., Wardlaw, A., TNF-α in asthma. Curr. Opin. Pharmacol. 7 (2007), 279–282, 10.1016/j.coph.2007.03.001.
183. [183] Staton, T.L., Choy, D.F., Arron, J.R., Biomarkers in the clinical development of asthma therapies. Biomark. Med 10 (2016), 165–176, 10.2217/bmm.15.116.
184. [184] Holgate, S.T., Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 120 (2007), 1233–1244, 10.1016/j.jaci.2007.10.025.
185. [185] Divekar, R., Kita, H., Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr. Opin. Allergy Clin. Immunol. 15 (2015), 98–103, 10.1097/ACI.0000000000000133.
186. [186] Kim, Y.H., Yang, T.Y., Park, C.-S., Ahn, S.-H., Son, B.K., Kim, J.H., Lim, D.H., Jang, T.Y., Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy 67 (2012), 183–190, 10.1111/j.1398-9995.2011.02735.x.